See it
early.

Blood biomarkers. Read together.

Biomarker panels and specialist machine learning. A product family built one disease at a time, starting with lung.

Meet VarSee Lung Available for research use
A branching pattern. An early signal.An original leaf-inspired illustration. As you scroll, fine branches draw outward and a gold point follows the central stem.LOOK CLOSER.FOLLOW THE PATTERN.
BioMarkIQ VarSee — the leaf mark

Life leaves a pattern.
We’re learning to read it earlier.

FROM BIOLOGY TO A CONNECTED VIEWFollow the pattern

What is VarSee?

VarSee is the product family being developed by BioMarkIQ. Our initial focus is lung cancer, where biomarker research and specialist machine learning come together around a specific disease question.

For research groups and laboratories, VarSee Lung is the starting point for a conversation about access, studies, and collaboration.

Explore VarSee Lung
VARSEE / LUNGFor research use only

Biology first.
Intelligence that connects it.

01

Biomarker evidence

Understand the biological question and the evidence behind candidate signals. Study what each measurement contributes to the complete panel.

02

Specialist intelligence

Explore how a mixture-of-experts architecture can consider specialist outputs in context. Different specialists contribute different readings of the biological pattern.

03

Appropriate evaluation

Define the intended use, population, and comparison. Distinguish model development from independent and combined-system evaluation.

The path to multi-cancer detection.

Multi-cancer early detection is a broader development ambition. Connecting disease programs introduces new questions about performance, follow-up, and usefulness in the intended population.

Understand the MCED approach

Lung first. Then the next cancer, built the same way.

Explore the work together.

Discuss a partnership